Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutation-specific T cells for immunotherapy of gliomas.

The New England journal of medicine - 14 May 2015

Melief Cornelis J M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Vaccines
Share to Disease Models, Animal
Share to Glioma
Share to Immunotherapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Mutant Proteins

Share to T-Lymphocytes, Helper-Inducer

Source

Identifiers

PMID: 25970054
DOI: 10.1056/NEJMcibr1501818

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutation-specific T cells for immunotherapy of gliomas.PMID 25970054Read ↗

CAR T cell therapy for glioblastoma: A review of the first decade of clinical trialsSemantic proximity Read ↗

Tumor mutational burden and immunotherapy in gliomasSemantic proximity Read ↗

Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.Semantic proximity Read ↗

Harnessing Tumor Mutations for Truly Individualized Cancer VaccinesSemantic proximity Read ↗

Gene Targets of CAR-T Cell Therapy for GlioblastomaSemantic proximity Read ↗

Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cellsSemantic proximity Read ↗

Personalized Medicine for GliomasSemantic proximity Read ↗

Adoptive T‐cell therapy for cancer: The era of engineered T cellsSemantic proximity Read ↗

Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in GlioblastomaSemantic proximity Read ↗

Developing neoantigen-targeted T cell–based treatments for solid tumorsSemantic proximity Read ↗

Adoptive T-Cell Therapy for Cancer.Semantic proximity Read ↗

Targeting cancer-specific mutations by T cell receptor gene therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.